Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $AUXL AUXILIUM PHARMACEUTICALS INC
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 5,773,365 shares
Latest Transaction: Mar 10 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in AUXILIUM PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, AUXL, GHDX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.75 | 550,000 | 12,513,765 | 5,773,365 | 5.2 M to 5.8 M (+10.53 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.44 | 115,000 | 2,695,060 | 5,223,365 | 5.1 M to 5.2 M (+2.25 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.17 | 117,273 | 2,717,344 | 5,108,365 | 5 M to 5.1 M (+2.35 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.81 | 58,388 | 1,331,976 | 4,991,092 | 4.9 M to 5 M (+1.18 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.51 | 1,948 | 43,845 | 4,932,704 | 4.9 M to 4.9 M (+0.04 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.86 | 48,657 | 1,112,299 | 4,930,756 | 4.9 M to 4.9 M (+1.00 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 22.88 | 86,227 | 1,972,693 | 4,882,099 | 4.8 M to 4.9 M (+1.80 %) |
| Mar 10 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 23.05 | 10,996 | 253,503 | 4,795,872 | 4.8 M to 4.8 M (+0.23 %) |
Page: 1